Using data from the ImproveCareNow Registry (ICN2), this collaborative study examines the frequency and variation in the use of immunomodulator therapy (azathioprine, 6-MP and methotrexate) with adalimumab (Humira). Funded by AbbVie.
Using data from the ImproveCareNow Registry (ICN2), this collaborative study examines the frequency and variation in the use of immunomodulator therapy (azathioprine, 6-MP and methotrexate) with adalimumab (Humira). Funded by AbbVie.
Built by Veracity Media on NationBuilder